Detalles de la búsqueda
1.
Clarifying responsibility: professional digital health in the doctor-patient relationship, recommendations for physicians based on a multi-stakeholder dialogue in the Netherlands.
BMC Health Serv Res
; 22(1): 129, 2022 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35094713
2.
A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint.
Oncoimmunology
; 7(8): e1466016, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30221065
3.
Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery.
ACS Synth Biol
; 5(10): 1146-1154, 2016 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27294279
4.
Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction.
Oncoimmunology
; 5(8): e1202390, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27622071
5.
C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity.
MAbs
; 7(2): 321-30, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25760768
6.
Designing and producing modified, new-to-nature peptides with antimicrobial activity by use of a combination of various lantibiotic modification enzymes.
ACS Synth Biol
; 2(7): 397-404, 2013 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23654279
7.
Melanoma-Directed Activation of Apoptosis Using a Bispecific Antibody Directed at MCSP and TRAIL Receptor-2/Death Receptor-5.
J Invest Dermatol
; 136(2): 541-544, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26967487
Resultados
1 -
7
de 7
1
Próxima >
>>